These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19631192)

  • 1. The serine protease HtrA2/Omi cleaves Parkin and irreversibly inactivates its E3 ubiquitin ligase activity.
    Park HM; Kim GY; Nam MK; Seong GH; Han C; Chung KC; Kang S; Rhim H
    Biochem Biophys Res Commun; 2009 Sep; 387(3):537-42. PubMed ID: 19631192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of Omi/HtrA2 protease leads to the deregulation of mitochondrial Mulan E3 ubiquitin ligase and increased mitophagy.
    Cilenti L; Ambivero CT; Ward N; Alnemri ES; Germain D; Zervos AS
    Biochim Biophys Acta; 2014 Jul; 1843(7):1295-307. PubMed ID: 24709290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HtrA2/Omi influences the stability of LON protease 1 and prohibitin, proteins involved in mitochondrial homeostasis.
    Goo HG; Rhim H; Kang S
    Exp Cell Res; 2014 Nov; 328(2):456-65. PubMed ID: 25094062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis.
    Yang QH; Church-Hajduk R; Ren J; Newton ML; Du C
    Genes Dev; 2003 Jun; 17(12):1487-96. PubMed ID: 12815069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress Conditions Increase Vimentin Cleavage by Omi/HtrA2 Protease in Human Primary Neurons and Differentiated Neuroblastoma Cells.
    Lucotte B; Tajhizi M; Alkhatib D; Samuelsson EB; Wiehager B; Schedin-Weiss S; Sundström E; Winblad B; Tjernberg LO; Behbahani H
    Mol Neurobiol; 2015 Dec; 52(3):1077-1092. PubMed ID: 25288153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel anti-apoptotic E3 ubiquitin ligase that ubiquitinates antagonists of inhibitor of apoptosis proteins SMAC, HtrA2, and ARTS.
    Kim JB; Kim SY; Kim BM; Lee H; Kim I; Yun J; Jo Y; Oh T; Jo Y; Chae HD; Shin DY
    J Biol Chem; 2013 Apr; 288(17):12014-21. PubMed ID: 23479728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced HtrA2/Omi expression in oxidative injury to retinal pigment epithelial cells and murine models of neurodegeneration.
    Ding X; Patel M; Shen D; Herzlich AA; Cao X; Villasmil R; Klupsch K; Tuo J; Downward J; Chan CC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4957-66. PubMed ID: 19443712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
    Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
    Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death.
    Park DW; Nam MK; Rhim H
    Biochem Biophys Res Commun; 2011 Nov; 415(1):24-9. PubMed ID: 22001920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
    Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
    J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
    J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo.
    Yun J; Cao JH; Dodson MW; Clark IE; Kapahi P; Chowdhury RB; Guo M
    J Neurosci; 2008 Dec; 28(53):14500-10. PubMed ID: 19118185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal.
    Vande Walle L; Wirawan E; Lamkanfi M; Festjens N; Verspurten J; Saelens X; Vanden Berghe T; Vandenabeele P
    Cell Res; 2010 Apr; 20(4):421-33. PubMed ID: 20125124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.
    Mandel H; Saita S; Edvardson S; Jalas C; Shaag A; Goldsher D; Vlodavsky E; Langer T; Elpeleg O
    J Med Genet; 2016 Oct; 53(10):690-6. PubMed ID: 27208207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice with neuron-specific overexpression of HtrA2/Omi suggest a neuroprotective role for HtrA2/Omi.
    Liu MJ; Liu ML; Shen YF; Kim JM; Lee BH; Lee YS; Hong ST
    Biochem Biophys Res Commun; 2007 Oct; 362(2):295-300. PubMed ID: 17707776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.
    Kemeny S; Dery D; Loboda Y; Rovner M; Lev T; Zuri D; Finberg JP; Larisch S
    PLoS One; 2012; 7(7):e38837. PubMed ID: 22792159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.
    Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H
    Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
    Pruefer FG; Lizarraga F; Maldonado V; Melendez-Zajgla J
    J Chemother; 2008 Jun; 20(3):348-54. PubMed ID: 18606591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Omi/HtrA2 with γ-secretase in mitochondria.
    Behbahani H; Pavlov PF; Wiehager B; Nishimura T; Winblad B; Ankarcrona M
    Neurochem Int; 2010 Nov; 57(6):668-75. PubMed ID: 20705111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
    Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
    J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.